PubMed Health⌕ Search

Biomedical subjects

D Newby

Publications and source records attributed to D Newby.

26 records · Page 2Linked to original sources

The incidence of negative symptoms in early schizophrenia, mania and other psychoses.

Despite increasing interest in negative symptoms in schizophrenia there has been little work on their incidence in early schizophrenia or in other psychoses. This study examined 79 nondepressive psychotics within 2 years of onset of illness, diagnosed by Research Diagnostic Criteria and assessed for negative symptoms using the Scale for the Assessment of Negative Symptoms. Marked negative symptoms were observed in nearly half of patients diagnosed as suffering definite schizophrenia and were rarely found in other psychoses. Negative symptoms were not significantly correlated with positive symptoms, depression or exposure to neuroleptics, but were correlated with developing extrapyramidal side effects.

Adult↗

Influence of food restriction coupled with weight cycling on carcass energy restoration during ad-libitum refeeding.

Mature (450 g) rats were subjected to food restriction (60 percent of usual intake) with or without weight cycling (produced by cycles of 3 days of fasting followed by 7 days of refeeding). Weight cycling did not affect body weight, body composition, or food efficiency during the restriction period. However, the group subjected to weight cycling (WC) had an elevated level of lipoprotein lipase (LPL) activity in the epididymal adipose tissue as compared to the group receiving a constant amount of food each day (CO). After 40 days (four 10-day cycles) of food restriction, rats were allowed ad-libitum access to a stock diet for 18 days. WC rats restored carcass energy more rapidly, with a greater food efficiency than CO rats. Carcass energy was not totally restored at the end of the 18-day period, but WC rats had regained significantly more total carcass energy and total fat-free dry weight (FFDW) than CO rats. Food intake during refeeding did not differ significantly between WC and CO rats. These results suggest that weight cycling in a food-restricted program has the potential to increase food efficiency during a subsequent refeeding period.

Adipose Tissue↗

A comparison of constant feeding with bouts of fasting-refeeding at three levels of nutrition in the rat.

To investigate whether intermittent fasting alters subsequent utilization of ingested energy, we compared, in six groups of 450-g male Wistar rats, two modalities of food delivery: constant (CO) vs fasting for 3 days and refeeding for 7 days (F/RF). Both modalities were investigated at three planes of nutrition (100, 60 and 40 percent of ad libitum). The F/RF groups were offered, during the 7 days of refeeding, the same amount of food as the CO groups were offered in 10 days. With both 60 and 40 percent food restriction, there were no differences in body weight, body composition, or energy utilization between the F/RF and the CO groups after 4 (40 days) or 8 (80 days) cycles of fasting-refeeding. However, at both 40 and 80 days of study, lipoprotein lipase (LPL) activity was significantly higher in F/RF rats than in CO rats at all three planes of nutrition. Because 100 percent F/RF rats did not eat all food available during each refeeding period, a second experiment was conducted. Rats were fasted for 3 days then refed ad libitum until they reached the weights of 100 percent CO rats. The two groups did not differ in body weight, food intake, body composition or LPL activity after 4 (40 days) fasting-refeeding cycles. Thus, weight cycling produced by repeated bouts of fasting-refeeding did not result in increased efficiency of energy utilization. However, the combination of fasting-refeeding and overall caloric restriction produced greater LPL activity than constant food restriction. It has not been determined whether this elevated LPL activity would affect lipid accumulation upon ad-libitum refeeding.

Adipose Tissue↗

Ceftazidime: a new approach in the treatment of moderate and severe infections.

Ninety patients with serious infections, including 61 with septicaemia, pneumonia, peritonitis or meningitis, were treated with ceftazidime. Of these patients, 85.6% were clinically cured (73.3%) or improved (12.2%) by the antibiotic. In this study, 57.7% had infections due to Escherichia coli (24.7%), Klebsiella sp. (14.5%) and Pseudomonas sp. (18.5%). Two children with cystic fibrosis and Pseudomonas pneumonia and an adult with Legionella pneumonia responded well to ceftazidime treatment. Seventy patients had fever before treatment and most of them became apyrexial in less than 2 to 3 days. Ceftazidime was given either intramuscularly (42 patients) or intravenously (48 patients), in a dose of 1 g tds in 71 patients or 2 g tds in severe infections in 11 patients, or reduced to suit the renal function (7 patients) or in paediatric doses (2 children). Blood ceftazidime levels were measured in eight patients with normal renal function. The average level one hour post dosing was 45.2 mg/l and the average trough level was 8.1 mg/l. Six patients were suffering from variable degrees of renal insufficiency (serum creatinine 149 to 668 mmol/l). Their average blood level 1 h post-dosing was 68.8 mg/l. In a patient with meningitis, the CSF level was 2.4 mg/l 2 h after a 1 g dose. These levels are several times the ceftazidime MIC values for most clinical bacterial isolates. Ceftazidime is a valuable and safe alternative to aminoglycoside therapy.

Adolescent↗

Heme oxygenase expression in cultured human trophoblast cells during in vitro differentiation: effects of hypoxia.

Heme oxygenases (HO-1 and HO-2) are responsible for the production of carbon monoxide, a vasodilator. HO is important in controlling placental blood flow and expression can be sensitive to oxygen. We previously reported a reduction in HO-2 expression in placentae obtained from patients with pre-eclampsia or living at high altitude, both associated with placental hypoxia. Thus we hypothesized that HO expression in cultured trophoblasts would be altered by exposure to hypoxia. HO-1 and HO-2 expression was assessed in trophoblast cell cultures following exposure to different oxygen environments. Western blot analyses showed that HO-1 expression in syncytiotrophoblast was significantly lower than in cytotrophoblasts in standard conditions (p < 0.05). There was no difference in HO-1 expression in cytotrophoblasts transferred to 2% O2 for various times. However, exposure of syncytiotrophoblast cultures to hypoxia for 12 h resulted in a significant reduction in HO-1 expression (p < 0.05). HO-2 expression was not affected by exposure to hypoxia in either cytotrophoblast or syncytiotrophoblast cultures. Possible interpretations of these findings are that chronic hypoxia alone is not responsible for reduced HO-2 expression or a much longer exposure to chronic hypoxia (perhaps months) is required. This study also reinforces the complexities of HO regulation by oxygen.

Adult↗

Alphafetoprotein and alphafetoprotein receptor expression in the normal human placenta at term.

Alphafetoprotein (AFP) is detectable in maternal serum from around six weeks of gestation and is synthesised by the yolk sac and the fetal liver. The role of the placenta in the transport and possible synthesis of AFP is uncertain. The aim of this study was to investigate placental expression of AFP and the AFP receptor in uncomplicated pregnancies at term. Immunohistochemistry and Western blotting clearly demonstrated the presence of AFP in villous tissue at term. However, evidence of AFP mRNA expression or synthesis of AFP was not found following reverse transcription polymerase chain reaction of total RNA isolated from villous tissue and trophoblast cell cultures. The presence of a cell surface receptor for AFP in placental villous tissue, identified by immunohistochemistry and Western blotting, suggests a possible receptor-mediated mechanism for placental transport of AFP while the patterns of expression of AFP and its receptor may indicate a possible route by which AFP is transported across the placenta between the fetal and maternal circulations. These findings demonstrate that the placenta does not synthesise AFP at term and that the presence of AFP in the placenta is a reflection of transplacental transport of AFP possibly via a receptor-mediated mechanism.

Adult↗

Placental synthesis of oestriol in Down's syndrome pregnancies.

In the second trimester, oestriol is synthesized in the placenta and secreted into the maternal circulation. 16alpha-hydroxy dehydroepiandrosterone sulphate (16alpha-OH-DHEAS) is formed in the fetal liver by hydroxylation of dehydroepiandrosterone sulphate (DHEAS) and transported to the placenta where it undergoes desulphation by steroid sulphatase (STS) and aromatization to oestriol. Maternal serum levels of unconjugated oestriol (UE3) are lower in Down's syndrome pregnancies than in unaffected pregnancies in the second trimester. The underlying cause of this variation was investigated in placenta, fetal liver, maternal serum and amniotic fluid from Down's syndrome pregnancies by measuring the levels of UE3, DHEAS and STS in appropriate tissues and in corresponding samples from unaffected pregnancies. UE3 levels, expressed as multiples of the control median at the appropriate gestation (MOM), were lower in placental tissue (0.52 MOM), maternal serum (0.65 MOM) and amniotic fluid (0.61 MOM) than in unaffected pregnancies. There was a significant correlation between placental and maternal serum levels of UE3 in the Down's syndrome cases. The median STS activity in placental tissue from Down's syndrome pregnancies (1.14 MOM) was not significantly different from that of the control pregnancies (1. 01 MOM), suggesting that placental turnover of the fetal precursor DHEAS is not reduced. However, levels of DHEAS were reduced in maternal serum (0.69 MOM), placental tissue (0.54 MOM) and fetal liver (0.65 MOM) from Down's syndrome pregnancies. Thus, a diminished supply of the fetal precursor DHEAS may be the cause of the decreased placental production of UE3 in Down's syndrome pregnancies in the second trimester.

Arylsulfatases↗